|
KIAA0776 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.131600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.268200E-01 |
| Normal-vs-Stage2 |
9.401400E-01 |
| Normal-vs-Stage3 |
8.888100E-02 |
| Normal-vs-Stage4 |
2.365600E-02 |
| Stage1-vs-Stage2 |
9.046800E-01 |
| Stage1-vs-Stage3 |
6.696200E-02 |
| Stage1-vs-Stage4 |
2.376300E-02 |
| Stage2-vs-Stage3 |
4.123400E-01 |
| Stage2-vs-Stage4 |
2.392200E-01 |
| Stage3-vs-Stage4 |
5.221400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.562000E-01 |
| Normal-vs-AfricanAmerican |
2.115800E-03 |
| Normal-vs-Asian |
1.827240E-01 |
| Caucasian-vs-AfricanAmerican |
4.178900E-03 |
| Caucasian-vs-Asian |
2.175200E-01 |
| AfricanAmerican-vs-Asian |
7.881200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.087620E-01 |
| Normal-vs-Female |
8.389400E-01 |
| Male-vs-Female |
7.208000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.798200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.706400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.035800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.719000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.213800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.904600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.031200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.926000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.327000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.082800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.094640E-01 |
| Normal-vs-Grade 2 |
2.751800E-01 |
| Normal-vs-Grade 3 |
6.301800E-02 |
| Normal-vs-Grade 4 |
2.24739999998835E-06 |
| Grade 1-vs-Grade 2 |
3.307800E-01 |
| Grade 1-vs-Grade 3 |
3.035600E-02 |
| Grade 1-vs-Grade 4 |
1.191380E-04 |
| Grade 2-vs-Grade 3 |
3.576600E-03 |
| Grade 2-vs-Grade 4 |
4.35420000055586E-08 |
| Grade 3-vs-Grade 4 |
4.795200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.023500E-03 |
| Normal-vs-ccB subtype |
7.562400E-04 |
| ccA subtype-vs-ccB subtype |
5.33340038799679E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.233400E-01 |
| Normal-vs-N1 |
3.437800E-02 |
| N0-vs-N1 |
5.856300E-02 |
|
|
